GER Equity Snapshot

NOT Weekly Equity Report

NOVARTIS AG N

Interactive chart JSON snapshot
Latest Close 132.4 EUR 12 Jun 2026
1W Return 3.0% latest completed week
4W Return 3.9% short-term follow-through
12W Return 4.6% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of …

Snapshot

What the weekly tape is saying

NOT closed the latest completed week at 132.4 EUR. The 4-week return is 3.9% and the 12-week return is 4.6%. Trend Signal is active, Market Dynamics is -0.62. Setup signature: Balanced read with a 63/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 6.3%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 77 Persistence of active Trend Signal over the last year and current streak.
Momentum 63 Blend of 4-week and 12-week follow-through.
Dynamics 40 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 86 Relative leadership and short-term RS change.
Volume 36 Participation compared with the 13-week volume baseline.
Risk Control 76 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
124.6 EUR
Vs Trend Line
6.3%
Fair Value
113.2 EUR
Vs Fair Value
17.0%
52W High
140.2 EUR
52W Low
94.14 EUR
Drawdown
-5.6%
Range Position
83.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 3.0%
4W 3.9%
12W 4.6%
26W 20.5%
52W 30.7%

Trend read

Active Streak
30 weeks
52W Active Weeks
30
52W Active Breadth
57.7%
Sector Scope
DE Healthcare
Sector Rank
7 of 80
Sector Percentile
92.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.62
4W MD Change
9.3%
Relative Strength
12.16
4W RS Change
-6.5%
Expectation
Positive
Probability
62.58%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
7.9K
13W Average
9.2K
52W Average
8.9K
Vs 13W
0.9x
Vs 52W
0.9x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.0%
52W Volatility
2.9%
Upside Weeks
31
Downside Weeks
21
Downside Breadth
40.4%
Avg Gain / Loss
2.5% / -2.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
GER
Country
DE
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Market Cap
247.9B

Opportunity signals

  • Trend Signal is active with a 30-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 132.4 EUR 3.0% 124.6 EUR 113.2 EUR -0.62 12.16 7.9K On
5 Jun 2026 128.6 EUR -1.0% 123.9 EUR 112.9 EUR -0.61 8.84 10.0K On
29 May 2026 129.9 EUR -0.6% 123.1 EUR 112.6 EUR -0.67 8.91 8.6K On
22 May 2026 130.6 EUR 2.5% 122.3 EUR 112.3 EUR -0.67 10.95 4.3K On
15 May 2026 127.4 EUR 3.0% 121.6 EUR 111.9 EUR -0.68 13.00 16.3K On
8 May 2026 123.7 EUR -2.2% 121.0 EUR 111.7 EUR -0.75 8.52 5.2K On
1 May 2026 126.4 EUR 2.8% 120.5 EUR 111.4 EUR -0.60 11.62 10.7K On
24 Apr 2026 122.9 EUR -4.8% 120.0 EUR 111.1 EUR -0.44 10.09 4.2K On
17 Apr 2026 129.1 EUR -2.0% 119.3 EUR 110.9 EUR -0.10 - 2.8K On
10 Apr 2026 131.7 EUR -1.3% 118.4 EUR 110.6 EUR 0.15 - 6.9K On
3 Apr 2026 133.4 EUR 2.9% 117.4 EUR 110.1 EUR 0.43 - 8.1K On
27 Mar 2026 129.6 EUR 2.4% 116.6 EUR 109.6 EUR 0.77 - 22.1K On
20 Mar 2026 126.6 EUR -5.8% 115.8 EUR 109.2 EUR 0.96 - 12.6K On
13 Mar 2026 134.4 EUR 1.3% 115.1 EUR 108.8 EUR 1.31 - 6.7K On